IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management III, LLC

Q2 2022 Holdings

Filed 2022-08-12 | 4 holdings | $12.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ascendis Pharma A/S(ASND)SPONSORED ADS04351P101$12.4M133,69199.9%
Natera, Inc.(NTRA)COM632307104$5.6K159,1600.0%
Cymabay Therapeutics, Inc.(CBAYUSD)COM23257D103$4.8K1,641,8040.0%
Verona Pharma Plc.(VRNA)SPONSORED ADS925050106$4.7K1,111,1120.0%